CLINUVEL to advance novel pharmaceutical formulations in preclinical program
Executive summary first biocompatible pharmaceutical formulations progress to preclinical modelsnew sustained-release drug…
LEQEMBI (lecanemab) IV Maintenance Dosing for the Treatment of Early Alzheimers Disease Approved in China
September 28, 2025 19:30 ET | Source: Biogen Inc. TOKYO and CAMBRIDGE,…
Glucose Health, Inc. Announces Officer Changes Effective September 30, 2025
September 26, 2025 16:00 ET | Source: Glucose Health BENTONVILLE, Ark., Sept.…
Scilex Holding Company Announces Closing of Previously Announced Initial Tranche Investment in Datavault AI
September 26, 2025 15:57 ET | Source: Scilex Holding Company PALO ALTO,…
Tekton Research Expands Clinical Network with Three New Sites, Five New Investigators, and CNS Thought Leader
AUSTIN, Texas, Sept. 26, 2025 (GLOBE NEWSWIRE) -- Tekton Research, a leading…
Oculis Publishes Notification of Transactions by Person Discharging Managerial Responsibilities
Accessibility: Skip TopNav ZUG, Switzerland, Sept. 26, 2025 (GLOBE NEWSWIRE) -- The…
Palisade Bio Announces Adjournment of Special Meeting of Stockholders Due to Lack of Quorum
Carlsbad, CA, Sept. 26, 2025 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (Nasdaq:…
Immuneering to Discuss Recently Announced Overall Survival Data from Phase 2a Clinical Trial of Atebimetinib + mGnP in First-Line Pancreatic Cancer Patients on Monday, September 29, 2025
NEW YORK, Sept. 26, 2025 (GLOBE NEWSWIRE) -- Immuneering Corporation (Nasdaq: IMRX),…
24/7 Market News: Kraig Labs Offers Safer, Natural Alternative to Health Risks from Nylon and Polyester Clothing
DENVER, Sept. 26, 2025 (GLOBE NEWSWIRE) -- 247marketnews.com, a pioneer in digital…
